摘要
肾移植被认为是治疗终末期肾病患者的金标准。应尽量减少缺血再灌注(IR)损伤,但这些损伤不可避免地发生在肾移植过程当中,还有一些临床环境,如心脏直视手术,假体植入等等也会发生。众所周知,缺血再灌注损伤主要存在肾移植过程中,因此,组织炎症和器官功能障碍会接踵而至,由于再灌注组织时发生氧化应激(OS),大量的活性氧生成,内源性抗氧化防御系统被破坏。此外,氧化应激与肾功能的损害密切相关,它可以为移植肾功能延迟恢复(DGF)创造条件,这是在肾移植过程中缺血再灌注损伤的常见临床表现。ω-3多不饱和脂肪酸(N - 3多不饱和脂肪酸)已广泛应用于不同的临床环境,以消除氧化应激的有害影响。因此,基于当前可用的文献,本文中心是提出一个基于n-3多不饱和脂肪酸在肾缺血再灌注损伤的氧化应激病理生理学中发挥着关键作用的战略目标,目的是为了降低抵抗移植肾功能延迟恢复的发生率。
关键词: 氧化应激,活性氧,缺血再灌注损伤,肾移植,移植肾功能延迟,欧米加3。
Current Medicinal Chemistry
Title:Role of Oxidative Stress in Renal Transplantation: Bases for an n-3 PUFA Strategy Against Delayed Graft Function
Volume: 24 Issue: 14
关键词: 氧化应激,活性氧,缺血再灌注损伤,肾移植,移植肾功能延迟,欧米加3。
摘要: Renal transplantation (RT) is considered the “gold standard” treatment for end-stage renal disease patients. Efforts should be made to reduce ischaemia-reperfusion (IR) injury, which unavoidably occurs in RT as long as several clinical settings, i.e. open-heart surgeries, prosthesis implantation, among others. It is well known that IR is primarily responsible for injury associated with RT. Consequently, tissue inflammation and organ dysfunction will ensue due to the occurrence of oxidative stress (OS) in the reperfused tissue, a condition generated when endogenous antioxidant defences become overwhelmed by a massive production of reactive oxygen species. Furthermore, OS is involved in the impairment of renal function, leading to deleterious conditions such as delayed graft function (DGF), which is a common clinical expression of IR injury in RT. Omega-3 polyunsaturated fatty acids (n -3 PUFA) have been widely used in different clinical settings to counteract the deleterious effects of OS. Thus, based on the currently available literature, the central aim of this review was to propose an n-3 PUFAbased strategy targeting the key role of OS in the pathophysiology of renal IR injury in order to encourage protection against the occurrence of DGF.
Export Options
About this article
Cite this article as:
Role of Oxidative Stress in Renal Transplantation: Bases for an n-3 PUFA Strategy Against Delayed Graft Function, Current Medicinal Chemistry 2017; 24 (14) . https://dx.doi.org/10.2174/0929867324666170227115435
DOI https://dx.doi.org/10.2174/0929867324666170227115435 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bradykinin B2 receptors play a neuroprotective role in Hypoxia/reoxygenation injury related to pyroptosis pathway
Current Neurovascular Research Role of Copper in Angiogenesis and Its Medicinal Implications
Current Medicinal Chemistry Cross-Talk Between Nitric Oxide and Transforming Growth Factor- β1 in Malaria
Current Molecular Medicine Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Hepatic Encephalopathy: Cause and Possible Management with Botanicals
Recent Patents on Inflammation & Allergy Drug Discovery Phytocompounds as Potential Agents to Treat Obesity-Cardiovascular Ailments
Cardiovascular & Hematological Agents in Medicinal Chemistry Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Current Neuropharmacology Pathophysiological Roles of Nitric Oxide: In the Heart and the Coronary Vasculature
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications
Current Pharmaceutical Design Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Current Alzheimer Research Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Editorial [Hot Topic: Nitric Oxide (Guest Editor: Greg Thatcher)]
Current Topics in Medicinal Chemistry The Evidence Base for Revascularisation of Chronic Total Occlusions
Current Cardiology Reviews Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase
Current Clinical Pharmacology Role of Redox Homeostasis and Inflammation in the Pathogenesis of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design